PHA-543613
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-105670-5MG | 5 mg | 185,00 | Add | |
| HY-105670-1ML | 10mM/1mL | 201,00 | Add | |
| HY-105670-10MG | 10 mg | 292,00 | Add | |
| HY-105670-25MG | 25 mg | 621,00 | Add | |
| HY-105670-50MG | 50 mg | 1'053,00 | Add | |
| HY-105670-100MG | 100 mg | 1'660,00 | Add | |
| HY-105670-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
PHA-543613 is a potent, orally active, brain-penetrant and selective α7 nAChR agonist with a Ki of 8.8 nM. PHA-543613 displays selectivity for α7-nAChR over α3β4, α1β1γδ, α4β2 and 5-HT3 receptors[1]. PHA-543613 can be used for the cognitive deficits of Alzheimer's disease and schizophrenia research[2].
| Category | Protein |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Neurological Disease, Membrane Transporter/Ion Channel,Neuronal Signaling |
| Format | Solubility: DMSO : 250 mg/mL (ultrasonic);H2O : 100 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.95% |
| Molecular Formula | C15H17N3O2 |
| Molecular Weight | 271.31 |
| CAS-Number | 478149-53-0 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
